The government has introduced substantial tariff relief measures targeting the pharmaceutical, logistics, and construction sectors. These reductions aim to lower operational costs and enhance competitiveness within these critical industries. By easing tariff burdens, the move is expected to stimulate investment and production, fostering overall economic development.
Pharmaceutical companies stand to benefit significantly as reduced tariffs on raw materials and equipment can lead to lower drug prices and improved access to medicines. Meanwhile, the logistics sector will gain from decreased import duties on transportation and warehousing equipment, potentially improving supply chain efficiency and reducing delivery times.
In a significant development for the construction industry, tariff relief on building materials and machinery is anticipated to accelerate infrastructure projects and housing development. This policy shift reflects the government’s commitment to supporting key economic drivers and addressing sector-specific challenges through targeted fiscal measures.
